Zhen Liu

Dr. Zhen Liu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2015 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
TYTing Yu
Ting Yu
LLLei Li
Lei Li
TCTianhua Chen
Tianhua Chen
ZLZhen Liu
Zhen Liu
HLHuaxiang Liu
Huaxiang Liu
ZLZhenzhong Li
Zhenzhong Li


1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YGYan Guo
Yan Guo
XXXiaobo Xu
Xiaobo Xu
JHJingyi Huang
Jingyi Huang
ZWZhen Wang
Zhen Wang
ZLZhenzhong Li
Zhenzhong Li
ZLZhen Liu
Zhen Liu
The proteasome inhibitor bortezomib (BTZ) is a potent first‐line anticancer drug for multiple myeloma; nonetheless, it induced peripheral neuropathy. It has been suggested that many cytokines may play a role in mediating neuropathic pain, but the underlying molecular mechanism is not fully understood. Recent studies have shown that neuropathic pain is closely related to the purinergic ligand‐gated ion channel 7 receptor (P2X7R), one of the P2X receptors, which is richly expressed in glial cells. P2X7‐p38 pathway is correlated with microglia‐ and satellite glial cell‐ (SGC‐) mediated neuropathic pain. However, the association of P2X7R and p38MAPK in mediating BTZ‐induced neuropathic pain remains unclear. In this study, the relationship between P2X7R activation and p38 phosphorylation in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) in the development and maintenance of BTZ‐induced neuropathic pain was elucidated. The results showed that BTZ increased mechanical thresholds in rats, accompanied with upregulation of P2X7R expression and p38MAPK phosphorylation, indicating that P2X7R and p38MAPK are key molecules in the development and maintenance of BTZ‐induced neuropathic pain. Inhibiting p38MAPK phosphorylation with SB203580 resulted in downregulation of P2X7R expression levels. Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 via inhibiting p38MAPK phosphorylation. The P2X7R/p38MAPK signaling pathway in SGCs of DRG and microglia of SDH might be a potential pharmacological target behind this mechanism as an opportunity to relieve BTZ‐induced neuropathic pain.

10 July 2016 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
XBXue Bai
Xue Bai
TCTianhua Chen
Tianhua Chen
YGYang Gao
Yang Gao
HLHao Li
Hao Li
ZLZhenzhong Li
Zhenzhong Li
ZLZhen Liu
Zhen Liu
Polybrominated diphenyl ethers (PBDEs) exist extensively in the environment as contaminants, in which 2,2′,3,3′,4,4′,5,5′,6,6′-decabrominated diphenyl ether (BDE-209) is the most abundant PBDE found in human samples. BDE-209 has been shown to cause neurotoxicity of primary sensory neurons with few effective therapeutic options available. Here, cultured dorsal root ganglion (DRG) neurons were used to determine the therapeutic effects of insulin-like growth factor-1 (IGF-1) on BDE-209-induced neurotoxicity. The results showed that IGF-1 promoted neurite outgrowth and cell viability of DRG neurons with BDE-209-induced neurotoxicity. IGF-1 inhibited oxidative stress and apoptotic cell death caused by BDE-209 exposure. IGF-1 could reverse the decrease in growth-associated protein-43 (GAP-43) and calcitonin gene-related peptide (CGRP), but not neurofilament-200 (NF-200), expression resulting from BDE-209 exposure. The effects of IGF-1 could be blocked by the extracellular signal-regulated protein kinase (ERK1/2) inhibitor PD98059 and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, either alone or in combination. IGF-1 may play an important role in neuroprotective effects on DRG neurons with BDE-209-induced neurotoxicity through inhibiting oxidative stress and apoptosis and regulating GAP-43 and CGRP expression of DRG neurons. Both ERK1/2 and PI3K/Akt signaling pathways were involved in the effects of IGF-1. Thus, IGF-1 might be one of the therapeutic agents on BDE-209-induced neurotoxicity.

1 August 2021 in Neuroscience Research
Verified
Journal Article
Closed access
YLYuantong Liu
Yuantong Liu
YSYue Shang
Yue Shang
ZYZihan Yan
Zihan Yan
HLHao Li
Hao Li
ZWZhen Wang
Zhen Wang
ZLZhen Liu
Zhen Liu